Detalhe da pesquisa
1.
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer.
Br J Cancer
; 128(2): 245-254, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36352028
2.
The impact of chemotherapy on cognitive performance post-surgery in patients with colorectal cancer: A prospective cohort study.
Psychooncology
; 32(7): 1057-1066, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208950
3.
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma.
Gut
; 68(6): 1052-1064, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30121627
4.
Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance.
Hum Mol Genet
; 26(8): 1552-1564, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28207045
5.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611518
6.
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma.
Br J Cancer
; 118(6): 793-801, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438372
7.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420616
8.
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.
Lancet Oncol
; 18(4): 486-499, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28259610
9.
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma.
BMC Cancer
; 16(1): 779, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27724887
10.
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 15(8): 829-40, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24954781
11.
Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion.
Mol Cancer
; 12: 1, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23286373
12.
HSP27 expression in primary colorectal cancers is dependent on mutation of KRAS and PI3K/AKT activation status and is independent of TP53.
Exp Mol Pathol
; 94(1): 103-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22982087
13.
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer.
Nat Commun
; 14(1): 5195, 2023 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673892
14.
A distinct DNA methylation profile associated with microsatellite and chromosomal stable sporadic colorectal cancers.
Int J Cancer
; 130(5): 1082-92, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21455990
15.
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
Lancet Oncol
; 12(7): 642-53, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21641867
16.
Harnessing cytokines and chemokines for cancer therapy.
Nat Rev Clin Oncol
; 19(4): 237-253, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997230
17.
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1ß.
Cancer Discov
; 12(9): 2140-2157, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771565
18.
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer.
Nat Commun
; 11(1): 4841, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32973176
19.
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Health Technol Assess
; 23(64): 1-88, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31852579
20.
The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner.
Nat Commun
; 9(1): 3279, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115931